remanded EB-2 (NIW)

Postdoctoral Research Associate

Chemical Biology And Medicinal Chemistry · 2022-03-09

Decision Date
2022-03-09
Location
Texas Service Center
This case is from a USCIS Administrative Appeals Office (AAO) appeal decision. Appeal cases represent a subset of petitions and may not reflect typical outcomes.

Proposed Endeavor

The petitioner proposes to specialize in medicinal chemistry, specifically focusing on the development of chemical probes and the synthesis of small molecule inhibitors for understudied protein kinases. This work is conducted within a School of Pharmacy to advance drug discovery and chemical biology.

Framework Evaluation

0 of 3 criteria met
1 Substantial Merit and National Importance Not Met

The Director did not render a determination as to whether the Petitioner satisfies prong one.

2 Well Positioned to Advance the Proposed Endeavor Not Met

The Director's analysis was found insufficient, particularly regarding the evaluation of recommendation letters and the petitioner's role in NIH-funded research.

3 On Balance, Beneficial to Waive Job Offer Not Met

The Director listed relevant factors but did not sufficiently evaluate the Petitioner's arguments and evidence.

Why This Petition Was Remanded

The appeal was remanded because the Director failed to provide a complete Dhanasar analysis, omitting a determination on prong one and providing insufficient reasoning for prongs two and three. The record noted the petitioner holds a Ph.D. in chemistry and submitted evidence including citation records, journal rankings, and NIH funding claims, though the latter required further verification of the petitioner's specific role.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants

Similar Cases

USCIS EB-2 (NIW) rfe remanded
University of South Carolina 2025-01-21
The petitioner proposes to pursue a position as a postdoctoral researcher, specifically expressing interest in the University of South Carolina. The endeavor involves research in a field where the petitioner specializes, with active discussions with various U.S. institutions.

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
Wisconsin 94 days 2025-01-29
The petitioner proposes to investigate the design, synthesis, optimization, and characterization of small molecule compounds. This work focuses on developing therapeutic agents to address drug-resistant infections and improve medication safety and efficacy.

Research Scientist

Research and Development · Taiwan

WeGreened EB-2 (NIW) approved
Indiana 552 days 2025-04-26
The petitioner proposes to develop advanced bioanalytical chemistry techniques to improve molecular characterization and expedite the drug discovery process. His work focuses on investigating biological processes driving neurodegenerative disorders, metabolic diseases, and cancer to facilitate new therapies. Additionally, he aims to enhance quality control measures within pharmaceutical manufacturing.

Research Scientist

Research and Development · Nepal

WeGreened EB-2 (NIW) approved
Pennsylvania 287 days 2022-03-07
The petitioner proposes to continue research on developing new chemical reactions to shorten synthetic routes and improve molecular complexity. This work aims to reduce the overall cost of developing drug therapies to treat cancer and other diseases by advancing the production of vital new pharmaceuticals.

Frequently Asked Questions

A remanded EB-2 NIW petition means the case was sent back to the field office for further review. This happens when procedural errors are found or additional evidence should be considered. It is neither an approval nor a denial.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-03-09.

Browse all cases

At a Glance

Outcome remanded
Criteria Met 0 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist